Jul 20, 2015 4:01 am EDT CollPlant Reports Positive Interim Trial Results for Vergenix™STR, for the Treatment of Tendinopathy
Jul 13, 2015 4:00 am EDT CollPlant Executes Non-binding Term Sheet to Develop and Commercialize a Novel Product for Spinal Fusion and Trauma Indications in Collaboration with Leading US Partner
Mar 19, 2015 8:57 am EDT CollPlant Reports Positive Interim Trial Results for Vergenix®FG Wound Healing Gel
Jan 12, 2015 11:04 am EST Another Clinical Trial for CollPlant: Trials for Vergenix®STR Have Begun - a Human Collagen-based Product for Tendon Repair
Dec 1, 2014 7:00 am EST CollPlant Launched a Clinical Trial With Vergenix®FG; A Gel Based on a Human Collagen for the Treatment of Chronic Wounds
Jun 23, 2014 9:16 am EDT CollPlant Holds Intellectual Property Rights in USA - One of the Largest Target Markets for the Company's Products: US Patent Office Approves Patent for Company's Collagen Production Techniques
Jun 16, 2014 11:53 am EDT CollPlant Takes a Step Closer to Commercializing its Vergenix Flowable Gel Product for Treating Wounds: Receives Approval to Carry Out Clinical Trial